CompletedNot Applicable

HTEMS Treatment of Diabetic Polyneuropathy

Germany80 participantsStarted 2020-10-20

Plain-language summary

So far, there are no sufficient pharmacologic therapies for the treatment of diabetic neuropathy. Therefore, we evaluated application of high-tone external muscle stimulation (HTEMS) compared to placebo treatment in patients with diabetic neuropathy.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * symptomatic diabetic neuropathy * stable oral analgesic regimen Exclusion Criteria: * history of drug or alcohol abuse * cardiac pacemaker or defibrillator * pregnancy

What they're measuring

Neuropathy symptom score

Timeframe: 12 weeks

Trial details

NCT IDNCT04593992

SponsorWest German Center of Diabetes and Health

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2021-10-31

View on ClinicalTrials.gov More Diabetic Polyneuropathy trials